Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$42.05 - $47.77 $10,260 - $11,655
-244 Reduced 2.03%
11,773 $512,000
Q1 2022

May 17, 2022

SELL
$40.23 - $47.74 $21,201 - $25,158
-527 Reduced 4.2%
12,017 $523,000
Q4 2021

Feb 15, 2022

SELL
$38.88 - $45.31 $64,268 - $74,897
-1,653 Reduced 11.64%
12,544 $553,000
Q3 2021

Nov 12, 2021

SELL
$38.79 - $43.16 $6,477 - $7,207
-167 Reduced 1.16%
14,197 $550,000
Q2 2021

Aug 12, 2021

BUY
$36.52 - $41.46 $14,133 - $16,045
387 Added 2.77%
14,364 $579,000
Q1 2021

May 13, 2021

BUY
$34.27 - $40.01 $6,682 - $7,801
195 Added 1.41%
13,977 $499,000
Q4 2020

Feb 08, 2021

BUY
$34.07 - $39.94 $203,466 - $238,521
5,972 Added 76.47%
13,782 $514,000
Q3 2020

Nov 12, 2020

BUY
$38.11 - $42.99 $30,183 - $34,048
792 Added 11.29%
7,810 $298,000
Q2 2020

Aug 12, 2020

BUY
$37.87 - $43.58 $10,452 - $12,028
276 Added 4.09%
7,018 $290,000
Q1 2020

May 13, 2020

SELL
$32.47 - $48.83 $14,384 - $21,631
-443 Reduced 6.17%
6,742 $259,000
Q4 2019

Feb 07, 2020

BUY
$42.0 - $48.25 $81,690 - $93,846
1,945 Added 37.12%
7,185 $342,000
Q3 2019

Nov 12, 2019

BUY
$40.46 - $43.52 $212,010 - $228,044
5,240 New
5,240 $226,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.2B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Lido Advisors, LLC Portfolio

Follow Lido Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lido Advisors, LLC with notifications on news.